Growth factor in connection with artificial implants

Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Tripeptides – e.g. – tripeptide thyroliberin – etc.

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530345, 525 541, A61K 3702, A61L 2700

Patent

active

053860128

ABSTRACT:
This invention utilizes the biological activity of the copper complex of the tripeptide glycyl-L-histidyl-L-lysine. This peptide is covalently bound to artificial implants where it has a chemoattractive effect and also acts when it is released by hydrolysis of the implants. The peptide increases fibroblastic collagen synthesis thereby enabling a more rapid replacement of the implants with human tissue.

REFERENCES:
patent: 4584284 (1986-04-01), Audhya et al.
patent: 4665054 (1987-05-01), Pickart
patent: 4767753 (1988-08-01), Pickart
patent: 4810693 (1989-03-01), Pickart
patent: 4877770 (1989-10-01), Pickart
patent: 4882162 (1989-11-01), Ikada et al.
patent: 5059588 (1991-10-01), Pickart

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Growth factor in connection with artificial implants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Growth factor in connection with artificial implants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Growth factor in connection with artificial implants will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1103293

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.